Evidence map›Paper›PMID 28757582›Full record

ArticleInternational journal of molecular sciences2017

Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril.

Fedor Simko, Olga Pechanova, Kristina Repova, Silvia Aziriova, Kristina Krajcirovicova, Peter Celec, Lubomira Tothova, Stanislava Vrankova, Lucia Balazova, Stefan Zorad and 1 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Lymphangiogenesis: A new strategy for heart disease treatment (Review).International journal of molecular medicine · 2024
    Review
  3. Review
  4. Review
  5. Review
  6. Melatonin as a Potential Approach to Anxiety Treatment.International journal of molecular sciences · 2022
    Review
  7. Review
  8. Evidence for the Benefits of Melatonin in Cardiovascular Disease.Frontiers in cardiovascular medicine · 2022
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Fedor SimkoInstitute of Pathophysiology, Faculty of Medicine, Comenius University, Sasinkova 4, 81108 Bratislava, Slovakia. fedor.simko@fmed.uniba.sk.
Olga PechanovaInstitute of Normal and Pathological Physiology, Slovak Academy of Sciences, 81371 Bratislava, Slovakia. olga.pechanova@savba.sk.
Kristina RepovaInstitute of Pathophysiology, Faculty of Medicine, Comenius University, Sasinkova 4, 81108 Bratislava, Slovakia. repova.k@gmail.com.
Silvia AziriovaInstitute of Pathophysiology, Faculty of Medicine, Comenius University, Sasinkova 4, 81108 Bratislava, Slovakia. silvia.aziriova@gmail.com.
Kristina KrajcirovicovaInstitute of Pathophysiology, Faculty of Medicine, Comenius University, Sasinkova 4, 81108 Bratislava, Slovakia. krikratina@gmail.com.
Peter CelecInstitute of Pathophysiology, Faculty of Medicine, Comenius University, Sasinkova 4, 81108 Bratislava, Slovakia. petercelec@gmail.com.
Lubomira TothovaInstitute of Molecular Biomedicine, Faculty of Medicine, Comenius University, 81108 Bratislava, Slovakia. tothova.lubomira@gmail.com.
Stanislava VrankovaInstitute of Normal and Pathological Physiology, Slovak Academy of Sciences, 81371 Bratislava, Slovakia. stanislava.vrankova@savba.sk.
Lucia BalazovaInstitute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, 84505 Bratislava, Slovakia. balazova.luc@gmail.com.
Stefan ZoradInstitute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, 84505 Bratislava, Slovakia. Stefan.Zorad@savba.sk.
Michaela AdamcovaDepartment of Physiology, Faculty of Medicine, Charles University, 50003 Hradec Kralove, Czech Republic. adamcova@lfhk.cuni.cz.
Comenius University Bratislava · SKSlovak Academy of Sciences · SKCharles University · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactacystin is a proteasome inhibitor that interferes with several factors involved in heart remodelling. The aim of this study was to investigate whether the chronic administration of lactacystin induces hypertension and heart remodelling and whether these changes can be modified by captopril or melatonin. In addition, the lactacystin-model was compared with N

Indexed as

AcetylcysteineAnimalsAntihypertensive AgentsCaptoprilDisease Models, AnimalFibrosisHeart VentriclesHypertensionLightMaleMelatoninNG-Nitroarginine Methyl EsterRatsRats, WistarVentricular RemodelingAcetylcysteineAntihypertensive AgentsCaptoprillactacystinMelatoninNG-Nitroarginine Methyl Estercaptoprilfibrosishypertensionlactacystinmelatoninremodelling

Identifiers

PMID28757582
PMCPMC5578004
OpenAlexW2739038561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.